Results 201 to 210 of about 63,241 (259)

Detection of AcrAB efflux pump mediated ciprofloxacin resistance in Escherichia coli and Klebsiella pneumoniae in Nepal. [PDF]

open access: yesBMC Infect Dis
Kharel S   +9 more
europepmc   +1 more source

Tackling cancer stemness with nanotechnology in the era of precision medicine

open access: yesBMEMat, EarlyView.
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo   +9 more
wiley   +1 more source

MexR and NalD are pyocyanin-responsive transcriptional repressors of the efflux pump MexAB-OprM in Pseudomonas aeruginosa. [PDF]

open access: yesNucleic Acids Res
Wu C   +10 more
europepmc   +1 more source

Structural and functional analysis of the <i>Mycobacterium tuberculosis</i> MmpS5L5 efflux pump presages increased bedaquiline resistance. [PDF]

open access: yesProc Natl Acad Sci U S A
Fountain AJ   +9 more
europepmc   +1 more source

Biocide Tolerance, Biofilm Formation, and Efflux Pump Activity in Clinical Isolates of <i>Trichosporon asahii</i>. [PDF]

open access: yesInfect Dis Rep
Passos Lima Y   +5 more
europepmc   +1 more source

Antibiotic efflux pumps

Biochemical Pharmacology, 2000
Active efflux from procaryotic as well as eucaryotic cells strongly modulates the activity of a large number of antibiotics. Effective antibiotic transport has now been observed for many classes of drug efflux pumps. Thus, within the group of primary active transporters, predominant in eucaryotes, six families belonging to the ATP-binding cassette ...
F, Van Bambeke, E, Balzi, P M, Tulkens
openaire   +2 more sources

Leishmaniasis: efflux pumps and chemoresistance

International Journal of Antimicrobial Agents, 2003
Resistance of parasitic protozoa such as Leishmania to therapeutic drugs continues to escalate in developing countries. Treatment programs for human leishmaniasis are still based on pentavalent antimonials but resistance to these compounds has been a persistent problem.
Clara, Leandro, Lenea, Campino
openaire   +2 more sources

Home - About - Disclaimer - Privacy